World CB & CDx USA

Almac Diagnostic Services is delighted to be attending World CB & CDx USA taking place in Boston, MA from 4th-6th September

About World CB & CDx USA

Across 2 days, 80+ world-class industry stakeholders will address the most critical challenges in Biomarker Discovery & Translational Development, Clinical Biomarker Development, and CDx Development & Commercialization, to provide you with unparalleled insights to:

• Recognizing biomarkers & CDx development advancements in multiple disease areas spanning oncology and non-oncology indications including NASH, Alzheimer’s & Parkinson’s to revolutionize personalized medicine efforts
• Exploring the regulatory, commercialization, and market access landscapes to take actional measures for the wider adoption and commercialization of testing and enable equitable access for patients
• Overcoming the challenges of analytically validating clinical biomarkers to ensure clinical trial robustness
• Utilize bioinformatics and AI for biomarker discovery, patient stratification, and clinical biomarker validation to enhance underlying biology and pathology understanding for biomarkers
• Collaborate with the hottest CDx developers to supercharge the co-development of therapeutics and companion diagnostics

For more information, click here.